{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:57:48Z","timestamp":1789541868553,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19590390"],"award-info":[{"award-number":["19590390"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clim.2013.10.013","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T16:34:16Z","timestamp":1383669256000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-apoptotic roles for the mutant p53R248Q through suppression of p53-regulated apoptosis-inducing protein 1 in the RA-derived fibroblast-like synoviocyte cell line MH7A"],"prefix":"10.1016","volume":"150","author":[{"given":"Hideya","family":"Igarashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Yahagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Saika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2013.10.013_bb0005","series-title":"Kelley's Textbook of Rheumatology","first-page":"201","article-title":"Fibroblasts and Fibroblast-like Synoviocytes","author":"Thomas","year":"2009"},{"key":"10.1016\/j.clim.2013.10.013_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2013.10.013_bb0015","series-title":"Rheumatoid Arthritis \u2014 Etiology, Consequences and Co-Morbidities","first-page":"73","article-title":"Molecular Mechanisms of Rheumatoid Arthritis Revealed by Categorizing Subtypes of Fibroblast-like Synoviocytes","author":"Ishihara","year":"2012"},{"key":"10.1016\/j.clim.2013.10.013_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2249.1998.00508.x","article-title":"Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue","volume":"111","author":"Reme","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2013.10.013_bb0025","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.94.20.10895","article-title":"Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium","volume":"94","author":"Firestein","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2013.10.013_bb0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/1529-0131(199908)42:8<1594::AID-ANR5>3.0.CO;2-#","article-title":"Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts","volume":"42","author":"Kullmann","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2013.10.013_bb0035","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1073\/pnas.152333199","article-title":"Regional analysis of p53 mutations in rheumatoid arthritis synovium","volume":"99","author":"Yamanishi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2013.10.013_bb0040","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1448","article-title":"p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis","volume":"7","author":"Yamanishi","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2013.10.013_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2249.2010.04163.x","article-title":"TP53 mutations coincide with the ectopic expression of activation-induced cytidine deaminase in the fibroblast-like synoviocytes derived from a fraction of patients with rheumatoid arthritis","volume":"161","author":"Igarashi","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2013.10.013_bb0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/carcin\/bgl132","article-title":"Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers","volume":"28","author":"Dearth","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clim.2013.10.013_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2220\/biomedres.31.401","article-title":"Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells","volume":"31","author":"Yoshikawa","year":"2010","journal-title":"Biomed. Res."},{"key":"10.1016\/j.clim.2013.10.013_bb0060","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(00)00073-8","article-title":"p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53","volume":"102","author":"Oda","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.clim.2013.10.013_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/ar1447","article-title":"Oxidation in rheumatoid arthritis","volume":"6","author":"Hitchon","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2013.10.013_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1097-2765(01)00284-2","article-title":"p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis","volume":"8","author":"Okamura","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.clim.2013.10.013_bb0075","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1074\/jbc.M512074200","article-title":"Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage","volume":"281","author":"Yoshida","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2013.10.013_bb0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7150\/ijbs.4283","article-title":"Surf the post-translational modification network of p53 regulation","volume":"8","author":"Gu","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.clim.2013.10.013_bb0085","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/1529-0131(199906)42:6<1088::AID-ANR4>3.0.CO;2-E","article-title":"Dominant-negative p53 mutations in rheumatoid arthritis","volume":"42","author":"Han","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2013.10.013_bb0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.clim.2013.10.013_bb0095","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1128\/MCB.00810-09","article-title":"Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser\/Thr\u2013Gln sequences","volume":"30","author":"Kodama","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.clim.2013.10.013_bb0100","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1073\/pnas.96.15.8438","article-title":"Hot-spot mutants of p53 core domain evince characteristic local structural changes","volume":"96","author":"Wong","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2013.10.013_bb0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/BJ20091888","article-title":"Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights","volume":"427","author":"Merabet","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2013.10.013_bb0110","doi-asserted-by":"crossref","first-page":"e27651","DOI":"10.1371\/journal.pone.0027651","article-title":"Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant","volume":"6","author":"Barakat","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2013.10.013_bb0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.molcel.2007.02.007","article-title":"DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage","volume":"25","author":"Taira","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.clim.2013.10.013_bb0120","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1371\/journal.pgen.0030127","article-title":"Divergent evolution of human p53 binding sites: cell cycle versus apoptosis","volume":"3","author":"Horvath","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.clim.2013.10.013_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/embor.2012.10","article-title":"Apak competes with p53 for direct binding to intron 1 of p53AIP1 to regulate apoptosis","volume":"13","author":"Yuan","year":"2012","journal-title":"EMBO Rep."},{"key":"10.1016\/j.clim.2013.10.013_bb0130","doi-asserted-by":"crossref","first-page":"a000935","DOI":"10.1101\/cshperspect.a000935","article-title":"Transcriptional regulation by p53","volume":"2","author":"Beckerman","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.clim.2013.10.013_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/rheumatology\/keh039","article-title":"Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts","volume":"43","author":"Itoh","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2013.10.013_bb0140","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1158\/0008-5472.CAN-06-0638","article-title":"Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2013.10.013_bb0145","first-page":"321","article-title":"Gene expression profiling of metastatic brain cancer","volume":"18","author":"Zohrabian","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.clim.2013.10.013_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clon.2007.08.006","article-title":"p53AIP1 expression can be a prognostic marker in non-small cell lung cancer","volume":"20","author":"Yamashita","year":"2008","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.clim.2013.10.013_bb0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1535-7163.113.4.1","article-title":"Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells","volume":"4","author":"Wesierska-Gadek","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.clim.2013.10.013_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1349-7006.2004.tb03176.x","article-title":"Adenovirus-mediated p53AIP1 gene transfer as a new strategy for treatment of p53-resistant tumors","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.clim.2013.10.013_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3892\/etm_00000057","article-title":"Adenovirus Ad-p53AIP1-mediated gene therapy and its regulation of p53-MDM2 interactions","volume":"1","author":"Jiang","year":"2010","journal-title":"Exp. Ther. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161300291X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161300291X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:56:52Z","timestamp":1761494212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161300291X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S152166161300291X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2013.10.013","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-apoptotic roles for the mutant p53R248Q through suppression of p53-regulated apoptosis-inducing protein 1 in the RA-derived fibroblast-like synoviocyte cell line MH7A","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2013.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}